GINA WHITE: Open Payments
NPI 1629813274 · NEW YORK MILLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$153 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $153
Food & beverage: $153
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Novo Nordisk Inc | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| ALK-Abello, Inc | 1 | $16 |
| Cumberland Pharmaceuticals, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: BREZTRI, Wegovy, XIFAXAN, TRELEGY ELLIPTA, AIRSUPRA, Odactra, KRISTALOSE, QULIPTA.
Industry payments across NY — which companies pay providers there.
